EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South Korea

Hyun-Woo Choi iD, Yoo-Ree Kang iD, Eun-Soon Son iD, Kyungsik Choi iD, Myungsun Cho iD, Young Jin Kim iD, Seo A Lee, Jin Young Lee iD, Jee Hey Kim iD, Seon Joo Kang iD, Seung-Jung Kee iD, Jong Seok Lee iD und 1 weitere

Pathogens · 2026

DOI: 10.3390/pathogens15030320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Hyun-Woo Choi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju 61496, Republic of Korea. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant tuberculosis is a major global health concern. Newer agents, including bedaquiline (BDQ), delamanid (DLM), pretomanid (PMD), and linezolid (LZD), are essential for treatment; however, the resistance mechanisms of these drugs remain poorly understood in South Korea. This study aimed to investigate correlations between phenotypic and genotypic resistance to these drugs using 49 clinical Mycobacterium tuberculosis isolates collected in South Korea between 2017 and 2022. The minimum inhibitory concentrations were determined using the 7H9 broth microdilution method, and whole-genome sequencing (WGS) results were compared with the May 2024 World Health Organization (WHO) mutation catalogue. Phenotypic drug susceptibility testing (pDST) revealed elevated MICs to BDQ in 12 isolates (24.5%), DLM in nine (18.4%), and PMD and LZD in two each (4.1%). No Group 1 or 2 resistance-associated mutations were detected in BDQ-, PMD-, or LZD-elevated-MIC isolates. A Group 2 mutation (fbiC_LoF) was observed in one DLM-elevated-MIC isolate, whereas fbiC_p.Ala855fs (WHO Group 2) mutations occurred in four susceptible isolates. These findings suggest resistance mechanisms beyond the current WHO catalog. Discrepancies between pDST and WGS highlight the need for integrated diagnostics and reinforce the importance of ongoing surveillance and refinement of mutation classification systems to improve genotypic resistance prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsRepublic of KoreaWhole Genome SequencingHumansPhenotypeMutationLinezolidNitroimidazolesGenotypeOxazoles

Stichwörter der Autor:innen

Mycobacterium tuberculosisbedaquilinedelamaniddrug-resistant tuberculosislinezolidpretomanid

Substanzen

Antitubercular AgentsLinezolidNitroimidazolesOPC-67683Oxazoles

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju 61496, Republic of Korea.
  • Laboratory Medicine Center, SD Medical Research Institute, Yongin 17013, Republic of Korea.
  • Microbiology Research Section, International Tuberculosis Research Center, Changwon 51755, Republic of Korea.
  • Laboratory Medicine Center, Korea National Tuberculosis Association, Seoul 06763, Republic of Korea.
  • Department of Laboratory Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.
  • Department of Biomedical Sciences, Graduate School of Chonnam National University, Gwangju 61186, Republic of Korea.

ORCID-Profile: Hyun-Woo Choi, Yoo-Ree Kang, Eun-Soon Son, Kyungsik Choi, Myungsun Cho, Young Jin Kim, Jin Young Lee, Jee Hey Kim, Seon Joo Kang, Seung-Jung Kee, Jong Seok Lee, Hee Joo Lee

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Choi, H. W., Kang, Y. R., Son, E. S., Choi, K., Cho, M., Kim, Y. J., Lee, S. A., Lee, J. Y., Kim, J. H., Kang, S. J., Kee, S. J., Lee, J. S., & Lee, H. J. (2026). Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South Korea. Pathogens. https://doi.org/10.3390/pathogens15030320

Vancouver

Choi HW, Kang YR, Son ES, Choi K, Cho M, Kim YJ, et al. Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South Korea. Pathogens. 2026. doi:10.3390/pathogens15030320

BibTeX
@article{Choi2026,
  author = {Choi, Hyun-Woo and Kang, Yoo-Ree and Son, Eun-Soon and Choi, Kyungsik and Cho, Myungsun and Kim, Young Jin and Lee, Seo A and Lee, Jin Young and Kim, Jee Hey and Kang, Seon Joo and Kee, Seung-Jung and Lee, Jong Seok and Lee, Hee Joo},
  title = {Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South Korea},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15030320}
}
Kostenlos starten →